Veradigm | MDRX - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Alcidion AUD 1.09M 184K 2025-12
Ambu A/S DKK 684M 5M 2026-03
Cardinal Health USD 1.62B 115M 2026-06
Centene USD 3.1B 294M 2026-06
Charles River Laboratories USD 228.9M 69.47M 2026-06
Cigna USD 3.47B 152M 2026-06
Coloplast 2.64B 52M 2025-12
Convatec Group USD 420.3M 210.35M 2024-12
Diasorin EUR 56M 49.25M 2026-03
Elevance Health USD 10.91B 309M 2025-12
General Electric Aerospace USD 1.13B 47M 2026-06
Gulf Medical Proj AED 806K 109K 2026-03
Humana USD 3.36B 614M 2025-03
IQVIA Holdings USD 574M 72M 2026-06
Laboratory Of America USD 577.2M 26.2M 2026-06
Maximus USD 167.19M 6.29M 2026-06
McKesson USD 2.26B 468M 2026-06
Med Life RON 26.47M 3.41M 2026-03
Molina Healthcare USD 1.23B 2.54B 2026-06
Omnicell USD 100.19M 1.8M 2026-06
Oriola-kd EUR 13M 3.1M 2025-09
Owens Minor USD 258.98M 7.5M 2025-12
Quest Diagnostics USD 529M 25M 2026-06
Rede D'or Sao Luiz BRL 27.72M 117.93M 2026-06
Siemens Healthineers EUR 1.01B 45M 2026-06
Sonova Holding CHF 880.2M 300K 2025-06
UnitedHealth USD 15.22B 1.44B 2025-09
Veeva Systems USD 126.47M 1.39M 2026-03
Veradigm USD 27.28M 5.24M 2022-12
Xerox USD 368M 10M 2025-06